Governing AI
Frameworks, Oversight & Accountability

What AI governance is
and why it matters for patient safety

AI governance in healthcare is the organizational infrastructure, policies, processes, and accountability structures that ensure AI systems are selected, deployed, monitored, and retired in ways that protect patients, support clinicians, comply with regulations, and advance the organization's mission. It is not a single policy document or a committee that meets quarterly. It is an ongoing operational commitment embedded in how the organization makes decisions about AI.

The case for AI governance is straightforward: AI systems deployed without governance cause harm. They are deployed in populations they were not designed for. They generate alerts that clinicians learn to ignore. They perpetuate historical inequities at algorithmic scale. They degrade in performance without detection. And when harm occurs, no one is accountable — because accountability was never assigned. Governance structures exist to prevent these outcomes.

Effective AI governance operates at three levels simultaneously: strategic — defining the organization's values and principles for AI use; operational — the processes for evaluation, approval, monitoring, and retirement of specific AI systems; and cultural — the behaviors, norms, and psychological safety that allow clinical staff to raise concerns about AI systems without fear of attribution or dismissal.

The AI Oversight &
Governance Committee

The AI Oversight and Governance Committee is the institutional body responsible for providing independent oversight, approval authority, and accountability for AI in clinical and operational settings. Its mandate, membership, decision authority, and reporting lines are the structural foundation of organizational AI governance.

Committee membership should include clinical expertise — physicians, nurses, pharmacists with relevant speciality knowledge; patient safety expertise — quality professionals who can assess AI risk in the context of broader safety systems; data and informatics expertise — clinical informatics specialists who can evaluate technical claims; independent perspective — members without direct operational involvement in AI deployment; and patient representation where possible — a dimension of AI governance that most organizations have not yet achieved.

The committee's decision authority should be unambiguous: it has the power to approve, condition, or reject AI deployments; to require performance monitoring reports and act on safety signals; to suspend deployed AI systems pending investigation; and to escalate significant AI risks to executive leadership and the board. Without these powers, the committee is advisory — and advisory is insufficient for patient safety governance.

The regulatory landscape
for healthcare AI

The regulatory environment for healthcare AI is evolving rapidly and varies significantly by jurisdiction. In the United States, the FDA regulates clinical AI as Software as a Medical Device (SaMD) — with different regulatory pathways depending on the risk level and the nature of the AI's clinical function. AI systems that support rather than replace clinical decision-making are generally subject to less stringent regulatory review than systems that make autonomous clinical recommendations.

The European Union's AI Act — the world's first comprehensive AI regulatory framework — classifies healthcare AI as high-risk and imposes rigorous requirements including transparency, human oversight, data governance, and post-market monitoring. The UK, Canada, and Australia are developing regulatory frameworks with varying approaches to pre-market evaluation and post-market surveillance.

For healthcare organizations, regulatory clearance is a necessary but not sufficient governance requirement. A device that is FDA-cleared or CE-marked has demonstrated safety and effectiveness under controlled validation conditions — it has not demonstrated safety and effectiveness in the specific patient population, workflow environment, and operational context of any particular deployment. Local governance remains essential regardless of regulatory status.

Key concepts
from this lesson